Difference between revisions of "Levamisole (Ergamisol)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
Line 5: Line 5:
 
==History of changes in FDA indication==
 
==History of changes in FDA indication==
 
*1990-06-18: indicated as adjuvant treatment in combination with [[Fluorouracil (5-FU)|5-fluorouracil]] after surgical resection in patients with Dukes' stage C [[colon cancer]]. ''(Based on Laurie et al. 1989 & SWOG S8591)''
 
*1990-06-18: indicated as adjuvant treatment in combination with [[Fluorouracil (5-FU)|5-fluorouracil]] after surgical resection in patients with Dukes' stage C [[colon cancer]]. ''(Based on Laurie et al. 1989 & SWOG S8591)''
 +
==History of changes in EMA indication==
 +
*1966-06-14: EURD
  
 
==Also known as==
 
==Also known as==
Line 15: Line 17:
  
 
[[Category:FDA approved in 1990]]
 
[[Category:FDA approved in 1990]]
 +
[[Category:EMA approved in 1966]]
 
[[Category:Discontinued drugs]]
 
[[Category:Discontinued drugs]]

Revision as of 23:08, 13 June 2023

This agent is not commercially available in the United States and is included for historic purposes only.

Diseases for which it was used

History of changes in FDA indication

  • 1990-06-18: indicated as adjuvant treatment in combination with 5-fluorouracil after surgical resection in patients with Dukes' stage C colon cancer. (Based on Laurie et al. 1989 & SWOG S8591)

History of changes in EMA indication

  • 1966-06-14: EURD

Also known as

  • Brand name: Ergamisol